Innovaro Facilitates the Licensing of Trojantec Ltd. Infectious Diseases Technology

Published: Jun 11, 2010

TAMPA, Fla.--(BUSINESS WIRE)--Innovaro (NYSE Amex: INV), a comprehensive innovation solutions company, is pleased to announce that it has facilitated the completion of a licensing transaction between Trojan Technologies USA, a company recently formed by Verdant Ventures Advisors II, LLC (Verdant Ventures), and Trojantec Ltd (heretofore “Trojantec”), a London and Cyprus based biopharmaceutical company.

Back to news